Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Mechanism of Microbicidal Action of E-101 Solution, a Myeloperoxidase-Mediated Antimicrobial, and Its Oxidative Products.

Denys GA, Devoe NC, Gudis P, May M, Allen RC, Stephens JT Jr.

Infect Immun. 2019 Jun 20;87(7). pii: e00261-19. doi: 10.1128/IAI.00261-19. Print 2019 Jul.

2.

Multicenter Evaluation of the Etest Gradient Diffusion Method for Ceftolozane-Tazobactam Susceptibility Testing of Enterobacteriaceae and Pseudomonas aeruginosa.

Bailey AL, Armstrong T, Dwivedi HP, Denys GA, Hindler J, Campeau S, Traczewski M, Humphries R, Burnham CA.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00717-18. doi: 10.1128/JCM.00717-18. Print 2018 Sep.

3.

Parallel Evaluation of the MALDI Sepsityper and Verigene BC-GN Assays for Rapid Identification of Gram-Negative Bacilli from Positive Blood Cultures.

Arroyo MA, Denys GA.

J Clin Microbiol. 2017 Sep;55(9):2708-2718. doi: 10.1128/JCM.00692-17. Epub 2017 Jun 21.

4.

Multicenter Evaluation of the Portrait Staph ID/R Blood Culture Panel for Rapid Identification of Staphylococci and Detection of the mecA Gene.

Denys GA, Collazo-Velez V, Young S, Daly JA, Couturier MR, Faron ML, Buchan BW, Ledeboer N.

J Clin Microbiol. 2017 Apr;55(4):1140-1146. doi: 10.1128/JCM.02348-16. Epub 2017 Jan 25.

5.

Propionibacterium acnes, Coagulase-Negative Staphylococcus, and the "Biofilm-like" Intervertebral Disc.

Coscia MF, Denys GA, Wack MF.

Spine (Phila Pa 1976). 2016 Dec 15;41(24):1860-1865.

6.

Linezolid-resistant Staphylococcus aureus strain 1128105, the first known clinical isolate possessing the cfr multidrug resistance gene.

Locke JB, Zuill DE, Scharn CR, Deane J, Sahm DF, Denys GA, Goering RV, Shaw KJ.

Antimicrob Agents Chemother. 2014 Nov;58(11):6592-8. doi: 10.1128/AAC.03493-14. Epub 2014 Aug 25.

7.

Antibiotic resistance in nosocomial respiratory infections.

Denys GA, Relich RF.

Clin Lab Med. 2014 Jun;34(2):257-70. doi: 10.1016/j.cll.2014.02.004. Epub 2014 Apr 13. Review.

PMID:
24856527
8.

Five-year longitudinal assessment (2008 to 2012) of E-101 solution activity against clinical target and antimicrobial-resistant pathogens.

Denys GA, Pillar CM, Sahm DF, O'Hanley P, Stephens JT Jr.

Antimicrob Agents Chemother. 2014 Aug;58(8):4911-4. doi: 10.1128/AAC.03020-14. Epub 2014 May 19.

9.

Portrait Toxigenic Clostridium difficile assay, an isothermal amplification assay detects toxigenic C. difficile in clinical stool specimens.

Denys GA.

Expert Rev Mol Diagn. 2014 Jan;14(1):17-26. doi: 10.1586/14737159.2014.864239. Epub 2013 Nov 28.

PMID:
24308336
10.
11.
12.

Multicenter clinical evaluation of the portrait toxigenic C. difficile assay for detection of toxigenic Clostridium difficile strains in clinical stool specimens.

Buchan BW, Mackey TL, Daly JA, Alger G, Denys GA, Peterson LR, Kehl SC, Ledeboer NA.

J Clin Microbiol. 2012 Dec;50(12):3932-6. doi: 10.1128/JCM.02083-12. Epub 2012 Sep 26.

13.

In vitro and in vivo activities of E-101 solution against Acinetobacter baumannii isolates from U.S. military personnel.

Denys GA, Davis JC, O'Hanley PD, Stephens JT Jr.

Antimicrob Agents Chemother. 2011 Jul;55(7):3603-8. doi: 10.1128/AAC.01606-10. Epub 2011 Apr 25.

14.

In vitro antibacterial activity of E-101 Solution, a novel myeloperoxidase-mediated antimicrobial, against Gram-positive and Gram-negative pathogens.

Denys GA, Grover P, O'Hanley P, Stephens JT Jr.

J Antimicrob Chemother. 2011 Feb;66(2):335-42. doi: 10.1093/jac/dkq429. Epub 2010 Nov 30.

PMID:
21118915
15.

Case report of Aurantimonas altamirensis bloodstream infection.

Mendes RE, Denys GA, Fritsche TR, Jones RN.

J Clin Microbiol. 2009 Feb;47(2):514-5. doi: 10.1128/JCM.02171-08. Epub 2008 Nov 26. No abstract available.

17.

Selection of a gyrA mutation and treatment failure with gatifloxacin in a patient with Streptococcus pneumoniae with a preexisting parC mutation.

Kays MB, Zhanel GG, Reimann MA, Jacobi J, Denys GA, Smith DW, Wack MF.

Pharmacotherapy. 2007 Feb;27(2):221-6.

PMID:
17253913
19.
20.

Levofloxacin treatment failure in a patient with fluoroquinolone-resistant Streptococcus pneumoniae pneumonia.

Kays MB, Smith DW, Wack ME, Denys GA.

Pharmacotherapy. 2002 Mar;22(3):395-9.

PMID:
11898897
21.
22.

Evaluation of BACTEC MYCO/F Lytic medium for recovery of mycobacteria, fungi, and bacteria from blood.

Fuller DD, Davis TE Jr, Denys GA, York MK.

J Clin Microbiol. 2001 Aug;39(8):2933-6.

24.
25.

APIC position paper: responsibility for interpretation of the PPD tuberculin skin test. Association for Professionals in Infection Control and Epidemiology, Inc.

DeCastro MG, Denys GA, Fauerbach LL, Ferranti JK, Hawkins K, Masters LC, Rimland D, Sharbaugh RJ, Zeller J.

Am J Infect Control. 1999 Feb;27(1):56-8.

PMID:
9949379
26.

APIC position paper: hepatitis C exposure in the health care setting. Association for Professionals in Infection Control and Epidemiology, Inc.

DeCastro MG, Denys GA, Fauerbach LL, Ferranti JK, Hawkins K, Masters LC, Rimland D, Sharbaugh RJ, Zeller J.

Am J Infect Control. 1999 Feb;27(1):54-5.

PMID:
9949378
27.

APIC position paper: immunization. Association for Professionals in Infection and Epidemiology, Inc.

DeCastro MG, Denys GA, Fauerbach LL, Ferranti JK, Hawkins K, Masters LC, Rimland D, Sharbaugh RJ, Zeller J.

Am J Infect Control. 1999 Feb;27(1):52-3.

PMID:
9949377
28.

Identification of Streptococcus pneumoniae with a DNA probe.

Denys GA, Carey RB.

J Clin Microbiol. 1992 Oct;30(10):2725-7.

29.
30.

Collaborative investigation of the accuracy and reproducibility of Sceptor Breakpoint susceptibility panels.

Denys GA, Hansen SL, Pope WA, Lilli H, Hejna JM.

J Clin Microbiol. 1987 Nov;25(11):2189-92.

31.
32.
33.

Possible prevention of an outbreak of group A streptococcal infection by a prospective epidemiologic approach.

Denys GA, Palacas JT, Lerner AM.

Infect Control. 1986 Jan;7(1):30-1. No abstract available.

PMID:
3512466
34.

Evaluation of a commercial exoantigen test system for the rapid identification of systemic fungal pathogens.

Denys GA, Newman MA, Standard PG.

Am J Clin Pathol. 1983 Mar;79(3):379-81.

PMID:
6402920
35.

Susceptibility of Propionibacterium acnes clinical isolates to 22 antimicrobial agents.

Denys GA, Jerris RC, Swenson JM, Thornsberry C.

Antimicrob Agents Chemother. 1983 Feb;23(2):335-7.

36.

An indirect fluorescent antibody technique for Haemophilus ducreyi.

Denys GA, Chapel TA, Jeffries CD.

Health Lab Sci. 1978 Jul;15(3):128-32.

PMID:
359505

Supplemental Content

Loading ...
Support Center